Literature DB >> 11600492

Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme.

A Merlos-Suárez1, S Ruiz-Paz, J Baselga, J Arribas.   

Abstract

Zinc-dependent metalloproteases can mediate the shedding of the extracellular domain of many unrelated transmembrane proteins from the cell surface. In most instances, this process, also known as ectodomain shedding, is regulated via protein kinase C (PKC). The tumor necrosis factor alpha-converting enzyme (TACE) was the first protease involved in regulated protein ectodomain shedding identified. Although TACE belongs to the family of metalloprotease-disintegrins, few members of this family have been shown to participate in regulated ectodomain shedding. In fact, the phenotype of tace-/- cells and that of Chinese hamster ovary cell mutants defective in ectodomain shedding points to the existence of a common PKC-activated ectodomain shedding system, whose proteolytic component is TACE, that acts on a variety of transmembrane proteins. Examples of these proteins include the Alzheimer's disease-related protein beta-amyloid precursor protein (betaAPP) and the transmembrane growth factors protransforming growth factor-alpha (pro-TGF-alpha) and, as shown in this report, proheparin-binding epidermal growth factor-like growth factor (pro-HB-EGF). Here we show that the mercurial compound 4-aminophenylmercuric acetate (APMA), frequently used to activate in vitro recombinant matrix metalloproteases, is an activator of the shedding of betaAPP, pro-HB-EGF, and pro-TGF-alpha. Treatment of tace-/- cells or Chinese hamster ovary shedding-defective mutants with APMA activates the cleavage of pro-TGF-alpha but not that of pro-HB-EGF or betaAPP, indicating that APMA activates TACE and also a previously unacknowledged proteolytic activity specific for pro-TGF-alpha. Characterization of this proteolytic activity indicates that it acts on pro-TGF-alpha located at the cell surface and that it is a metalloprotease active in cells defective in furin activity. In summary, treatment of shedding-defective cell lines with APMA unveils the existence of a metalloprotease activity alternative to TACE with the ability to specifically shed the ectodomain of pro-TGF-alpha.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600492     DOI: 10.1074/jbc.M103488200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Shooting from the hip: spatial control of signal release by intracellular waves.

Authors:  Stanislav Y Shvartsman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

2.  Long-range signal transmission in autocrine relays.

Authors:  Michal Pribyl; Cyrill B Muratov; Stanislav Y Shvartsman
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

3.  ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway.

Authors:  Ping Lin; Xicai Sun; Tian Feng; Haifeng Zou; Ying Jiang; Zijun Liu; Dandan Zhao; Xiaoguang Yu
Journal:  Mol Cell Biochem       Date:  2011-08-12       Impact factor: 3.396

4.  Anti-microRNA-222 (anti-miR-222) and -181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal.

Authors:  Yuanzhi Lu; Satavisha Roy; Gerard Nuovo; Bhuvaneswari Ramaswamy; Tyler Miller; Charles Shapiro; Samson T Jacob; Sarmila Majumder
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

5.  The Functional Maturation of A Disintegrin and Metalloproteinase (ADAM) 9, 10, and 17 Requires Processing at a Newly Identified Proprotein Convertase (PC) Cleavage Site.

Authors:  Eitan Wong; Thorsten Maretzky; Yoav Peleg; Carl P Blobel; Irit Sagi
Journal:  J Biol Chem       Date:  2015-03-20       Impact factor: 5.157

6.  Inhibition of doxorubicin-induced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cells.

Authors:  Martin Bezler; Jan G Hengstler; Axel Ullrich
Journal:  Mol Oncol       Date:  2012-07-20       Impact factor: 6.603

7.  Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.

Authors:  Keisuke Horiuchi; Sylvain Le Gall; Marc Schulte; Takafumi Yamaguchi; Karina Reiss; Gillian Murphy; Yoshiaki Toyama; Dieter Hartmann; Paul Saftig; Carl P Blobel
Journal:  Mol Biol Cell       Date:  2006-11-01       Impact factor: 4.138

8.  Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity.

Authors:  Minji Kim; Jaehong Suh; Donna Romano; Mimy H Truong; Kristina Mullin; Basavaraj Hooli; David Norton; Giuseppina Tesco; Kathy Elliott; Steven L Wagner; Robert D Moir; K David Becker; Rudolph E Tanzi
Journal:  Hum Mol Genet       Date:  2009-07-15       Impact factor: 6.150

9.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

10.  Essential role for ADAM19 in cardiovascular morphogenesis.

Authors:  Hong-Ming Zhou; Gisela Weskamp; Valérie Chesneau; Umut Sahin; Andrea Vortkamp; Keisuke Horiuchi; Riccardo Chiusaroli; Rebecca Hahn; David Wilkes; Peter Fisher; Roland Baron; Katia Manova; Craig T Basson; Barbara Hempstead; Carl P Blobel
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.